Halozyme
HALO
336 hedge funds and large institutions have $5.51B invested in Halozyme in 2021 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 127 increasing their positions, 128 reducing their positions, and 48 closing their positions.
43% more call options, than puts
Call options by funds: $18.8M | Put options by funds: $13.1M
1% less repeat investments, than reductions
Existing positions increased: 127 | Existing positions reduced: 128
2% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 48
2% less funds holding
Funds holding: 342 → 336 (-6)
3.01% less ownership
Funds ownership: 100.85% → 97.84% (-3%)
5% less capital invested
Capital invested by funds: $5.81B → $5.51B (-$303M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Swedbank
Stockholm,
Sweden
|
+$38.7M |
| 2 |
HM
HealthCor Management
New York
|
+$34M |
| 3 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$28.4M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$20.2M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$17.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$47.2M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
-$46.8M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$29.3M |
| 4 |
TS
Third Security
Radford,
Virginia
|
-$28.9M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$25.6M |
HALO Hedge Fund Activity: Q1 2021 in Review
336 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q1 2021, worth a combined $5.51B — down 5.2% from $5.81B a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of HALO and 47 opened new positions — a net loss of 1 holder — while 128 trimmed existing stakes and 127 added.
The largest buyer was Swedbank, opening a new position worth an estimated $38.7M. The largest seller was Bellevue Group, cutting an estimated $47.2M.
- 336 institutional investors held Halozyme (HALO) as of Q1 2021, down from 342 in Q4 2020.
- Funds reported $5.51B of Halozyme stock for Q1 2021, down 5.2% quarter-over-quarter.
- 47 funds opened new Halozyme positions in Q1 2021 and 48 closed out, a net change of -1 holder.
- The largest Halozyme buyer in Q1 2021 was Swedbank, an estimated $38.7M added.
- The largest Halozyme seller in Q1 2021 was Bellevue Group, an estimated $47.2M sold.
Based on aggregated 13F filings for Q1 2021.